Literature DB >> 15577566

Controversy in the management of retinal venous occlusive disease.

Srilaxmi Bearelly1, Sharon Fekrat.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15577566     DOI: 10.1097/00004397-200404440-00008

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


× No keyword cloud information.
  4 in total

1.  Intravitreal injection of bevacizumab alone or with triamcinolone acetonide for treatment of macular edema caused by central retinal vein occlusion.

Authors:  Hai-Yan Wang; Xiao Li; Yus-Sheng Wang; Zi-Feng Zhang; Man-Hong Li; Xiao-Na Su; Jin-Ting Zhu
Journal:  Int J Ophthalmol       Date:  2011-02-18       Impact factor: 1.779

2.  Peripheral retinal non-perfusion and treatment response in branch retinal vein occlusion.

Authors:  Kaveh Abri Aghdam; Lukas Reznicek; Mostafa Soltan Sanjari; Carsten Framme; Anna Bajor; Annemarie Klingenstein; Marcus Kernt; Florian Seidensticker
Journal:  Int J Ophthalmol       Date:  2016-06-18       Impact factor: 1.779

3.  Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion: 6 months of follow-up.

Authors:  Rita Ehrlich; Thomas A Ciulla; Adam M Moss; Alon Harris
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-11-08       Impact factor: 3.117

4.  COMBINED TREATMENT WITH BEVACIZUMAB AND TRIAMCINOLONE ACETONIDE FOR MACULAR EDEMA DUE TO RETINAL VEIN OCCLUSION.

Authors:  Maja Vinković; Damir Bosnar; Eugenia Tedeschi Reiner; Gabriella De Salvo; Suzana Matić
Journal:  Acta Clin Croat       Date:  2020-12       Impact factor: 0.932

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.